Target intelligence / Profile preview

Host intestinal epithelial cell surface receptors (None)

Target
None
Molecular classification
Receptor, Ion channel, Transporter, Enzyme, Cell adhesion molecule, G protein-coupled receptor
01

Overview

Host intestinal epithelial cell surface receptors refer to the heterogeneous array of proteins located on the plasma membrane of the cells forming the intestinal barrier. These receptors are fundamental to gastrointestinal physiology, governing the selective uptake of nutrients, the secretion of ions and water, and the sensing of the luminal environment [Peterson & Artis, 2014]. They play a dual role in disease: serving as essential components of the innate immune system through pattern recognition (e.g., TLRs) and acting as "gateways" for enteric pathogens and toxins [Guyer et al., 2021]. For example, the ACE2 receptor on enterocytes is a known entry point for SARS-CoV-2, while Guanylate cyclase-C is a validated target for treating chronic constipation [Hoffmann et al., 2020; NIH, 2023]. Because this term describes a location-based collection of proteins rather than a single molecular entity, it is considered too broad for specific drug development programs. Analysts should instead focus on specific receptor sub-types or individual proteins within this category to evaluate therapeutic potential and safety profiles.

Other names
Intestinal epithelial surface proteinsGut epithelial receptorsEnterocyte surface receptorsIntestinal mucosal receptors
02

Mechanism of action

Varies by specific receptor; includes agonism of Guanylate cyclase-C to increase fluid secretion, inhibition of ion transporters (e.g., NHE3) to reduce sodium absorption, and modulation of pattern recognition receptors to manage inflammation [NIH, 2023].

03

Biological functions

Nutrient absorptionBarrier functionImmune responseSignal transductionElectrolyte transportPathogen sensing
04

Disease associations

InfectionInflammationMalabsorptionCancerCystic fibrosisCeliac disease
05

Safety considerations

DiarrheaElectrolyte imbalanceDisruption of the mucosal barrierAltered nutrient absorptionIncreased susceptibility to enteric infections
06

Interacting drugs

Linaclotide

4 more in the full profile.

07

Biomarkers

Fecal calprotectinCitrullineZonulinACE2 expression levelsGuanylate cyclase-C expression

Beyond the preview

Go deeper on Host intestinal epithelial cell surface receptors (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal epithelial cell surface receptors (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call